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Abstract
Background: Quince (Cydonia oblonga Miller) is a deciduous shrub belonging to the Rosaceae family. Quince seed
extract has long been used as a cosmetic ingredient for its moisturizing effect. However, little is known about
whether quince seed extract has therapeutic effects on keratinocyte-associated skin inflammation.
Methods: In the present study, we investigated the effect of the topical application of ethanol extract of quince
seeds (QSEtE) on atopic dermatitis (AD) symptoms in NC/Nga mice. The direct effect of QSEtE on keratinocytes was
evaluated using the human keratinocyte cell line HaCaT.
Results: The preliminary application of QSEtE markedly reduced house dust mite allergen-induced skin lesions. The
expression of thymus- and activation-regulated chemokine (TARC) in dorsal skin was downregulated. QSEtE directly
suppressed the expression and production of TARC in HaCaT cells.
Conclusions: The results suggest that the topical application of QSEtE is effective in preventing the onset of and
ameliorating the atopic symptoms of keratinocyte-associated skin inflammation by suppressing TARC production in
keratinocytes.
Keywords: Quince seed, Cydonia oblonga, Atopic dermatitis, Keratinocyte, Thymus- and activation-regulated
Chemokine
Background
Quince (Cydonia oblonga Miller) is a deciduous shrub
that belongs to the Rosaceae family and has been mainly
cultivated in Asia and areas of the Mediterranean since
ancient times [1]. Although quince fruit is not edible
owing to its hard, tough and fibrous consistency, it has
been used in honeydew and liquors for its pleasant
aroma [2]. In addition, peculiar mucilage, which is a
mixture of cellulose and water-soluble polysaccharides,
is obtained from quince seeds by soaking them in water
[3]. The mucilage is reported to have proliferation-
enhancing effect on skin fibroblasts [4], healing effects
on incised wounds [5], and protective effects against
dermal toxicity caused by T2-toxin [6]. Therefore, the
mucilage from quince seeds has long been used as a
cosmetic ingredient, known as “quince seed extract”, to
maintain the barrier function of the skin [7]. However,
little is known about the physiological effect of quince
seed extract on skin keratinocytes, and the associated
onset of atopic side effects on the skin.
Atopic dermatitis (AD) is a chronic inflammatory skin
disease associated with intense pruritus and a series of
exacerbations and remissions [8]. AD is recognized as a
type I and type IV complex according to the Coombs
and Gell classification system [9]. Both T-helper (Th2)
type immunologic reactions and T-cell-mediated delayed
hypersensitivity are involved in AD. In addition, it has
been recognized that the expression of various
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inflammatory chemokines produced by keratinocytes
plays important roles in the pathogenesis of AD [10].
In the present study, we aimed to evaluate whether
quince seeds have a suppressive effect on the incidence
and development of allergic inflammation in the skin.
For this purpose, an AD model mouse and a human
keratinocyte cell line were used.
Methods
Preparation of QSEtE
The fruits of quince ‘Smyrna’ were purchased from the
fruit farm in the Minamiminowa-mura area of Nagano,
Japan and were formally surveyed and identified at the
Laboratory for Postharvest Science and Functional
Properties of Fruits and Vegetables. Twenty grams of
seeds was separated from the fruits and immersed in
80 mL ethanol. Then, extraction was performed for 1 week
at room temperature. The ethanol extract was then fil-
tered using a Buchner funnel with filter paper discs to re-
move insoluble residues. Then, the extract was dissolved
in water after removal of ethanol and lyophilized using an
FD-5 N freeze dryer (EYELA) to obtain powdered QSEtE.
We re-constituted QSEtE in ethanol at the indicated
concentrations and sterilized using a 0.2-μm pore size cel-
lulose acetate membrane filter (Advantec, Tokyo, Japan)
before use.
Mice
Specific pathogen-free, female NC/Nga mice, aged
10 weeks, with 19–23 g body weight were purchased
from Charles Liver Laboratories Japan, Inc. (Kanagawa,
Japan). The animals were housed at 23 ± 3 °C under a
12-h light/dark cycle and acclimatized for 7 days in
laboratory condition before experiments. Food and water
were provided ad libitum. All animal protocols were
approved by the Committee for Animal Experiments of
Shinshu University (Matsumoto, Japan).
Induction of dermatitis
A schematic procedure of the topical application of QSEtE
to NC/Nga mice is shown in Fig. 1. At the start of the ex-
periment, mice were randomly divided into the following
three groups (n = 6 for each group): ethanol-treated group
(vehicle), 0.1% (w/v) QSEtE/ethanol-treated group (0.1%
QSEtE), and 1.0% (w/v) QSEtE/ethanol-treated group
(1.0% QSEtE). The experimental unit is a cage with a sin-
gle animal. AD-like skin lesions were induced by topical
application of Biostir-AD (Biostir, Kobe, Japan), a hydro-
philic petrolatum-based ointment-containing extract of
house dust mite (Dermatophagoides farinae), according to
the manufacturer’s instructions. The hair on the upper
dorsal skin and the back of the ears of mice was shaved
under isoflurane anaesthesia, and 100 μL of 4% (w/v)
sodium dodecyl sulphate was applied to shaved skin for
barrier disruption. After 3 h, 100 μL ethanol (vehicle),
0.1% QSEtE in ethanol, or 1.0% QSEtE in ethanol was ap-
plied to the area twice a week. Then, the following week,
Biostir-AD was applied to the skin area immediately after
QSEtE application. The application of the test substrate
and Biostir-AD was repeated twice weekly for a further
3 weeks. On day 28 of the experiment, mice were sacri-
ficed by cervical dislocation. Then, the ear and dorsal skin
were harvested for histological analyses and analysis of
gene expression, respectively. Any clinical signs related to
toxicity, such as remarkable loss of body weight, were
monitored in all groups of animals throughout the course
of experiment.
Evaluation of the severity of skin lesions
The severity of dermatitis was evaluated according to a
previously described method [11]. Briefly, the develop-
ment of erythema haemorrhage, scarring dryness,
oedema and excoriation erosion was scored as 0 (none),
1 (mild), 2 (moderate) and 3 (severe). The sum of the in-
dividual scores was taken as the dermatitis score.
Fig. 1 Experimental design of QSEtE application. To induce AD-like symptoms, Biostir-AD was topically applied to the skin of NC/Nga mice twice
weekly for 3 weeks. Mice were either treated with QSEtE dissolved in ethanol (0.1 or 1.0% QSEtE), or ethanol alone (vehicle) twice weekly 1 week
prior to the application of Biostir-AD application
Kawahara et al. BMC Complementary and Alternative Medicine  (2017) 17:80 Page 2 of 8
Histopathological studies
The harvested ear of mice was immediately fixed in 10%
(v/v) neutral buffered formalin and left for 48 h. Then,
the fixed ear was sliced and embedded in paraffin,
sectioned, deparaffinised and rehydrated at the
Biopathology Institute Co., Ltd. (Oita, Japan). The proc-
essed sections were either subjected to hematoxylin and
eosin staining to evaluate oedema, or subjected to tolui-
dine blue staining to evaluate infiltrated mast cells.
Cells
A human keratinocyte cell line, HaCaT, was purchased
from Cell Lines Service GmbH (Eppelheim, Germany).
HaCaT cells were cultured using high glucose Dulbecco’s
modified Eagle’s medium (Wako Pure Chemical Indus-
tries, Ltd., Osaka, Japan) supplemented with 10% heat-
inactivated foetal bovine serum (Equitech-Bio, Kerrville,
TX, USA), 2 M L-glutamine, 100 U/mL penicillin G and
100 μg/mL streptomycin. Cells were passaged using con-
ventional procedures with 0.05% trypsin in a humidified
atmosphere of 5% CO2/95% air at 37 °C.
Induction of thymus and activation-regulated chemokine
(TARC)
TARC was induced from HaCaT cells according to the
method of Sumiyoshi et al. [12]. Briefly, HaCaT cells
(2.5 × 105 cells/1 mL/well) were seeded in a 24-well
tissue culture plate (Falcon; Corning Incorporated,
Corning, NY, USA) and cultured with the aforemen-
tioned concentrations of QSEtE for 24 h. The cells were
then stimulated with 10 ng/mL human recombinant
tumour necrosis factor (TNF)-α (PeproTech, Rocky Hill,
NJ, USA) and 10 ng/mL human recombinant interferon
(IFN)-γ (PeproTech). After 6 h, the cells were subjected
to quantitative reverse transcription-polymerase chain
reaction (qRT-PCR). The culture supernatant was
collected 24 h after stimulation and stored at −80 °C for
enzyme-link immunosorbent assay (ELISA).
qRT-PCR
TARC mRNA expression in HaCaT cells was analysed by
qRT-PCR. Total RNA was extracted from cells using TRI re-
agent (Merck Millipore, Darmstadt, Germany) according to
the manufacturer’s protocol. The extracted RNA (1 μg) was
reverse transcribed in a thermal cycler (PTC-200; MJ
Research, Waltham, MA, USA) with 1 mM dNTP, 2.5 U/
μL M-MLV reverse transcriptase (Thermo Fisher Scientific,
Roskilde, Denmark) and 10 pmol/μL random primer at
42 °C for 50 min. qRT-PCR was performed using 0.5 μg
cDNA with SYBR Premix Ex Taq II (Takara Bio, Otsu,
Japan) and 10 pmol/μL primers. The primer sequences for
human TARC (GenBank: NM_002987.2) were designed as
5′-TTTGAGCTCACAGTGTCACC-3′ (forward) and 5′-
GGAGTCTCTGTGTGCAGGTC-3′ (reverse), and were
complementary to 18–37 and 110–91, respectively. The
primer sequences for human glyceraldehyde-3-phosphate
dehydrogenase (GAPDH; GenBank: AF261085.1) were
designed as 5′- CTGCTCCTCCTGTTCGACAG-3′ (for-
ward) and 5′- GCGCCCAATACGACCAAATC-3′ (re-
verse), and were complementary to 33–52 and 151–132,
respectively. PCR comprised 1 cycle of preheating (95 °C,
10 min), 40 cycles of denaturation (95 °C, 10 s), and pri-
mer annealing and extension (55 °C, 30 s) using an Eco
Real Time PCR System (Illumina, San Diego, CA, USA).
Results were analysed with the ΔΔCt method using Eco
system software (Illumina). The amounts of PCR products
were normalised to the expression level of GAPDH
mRNA.
ELISA
IgE level in mice serum and TARC produced by HaCaT
cells in culture supernatant were measured using sand-
wich ELISA. The detailed procedure to measure IgE was
described previously [13]. To measure TARC, 50 μL of
2 μg/mL mouse anti-human TARC (R & D Systems,
Minneapolis, MN, USA) dissolved in 0.1 M carbonate
buffer (pH 10.0) was added to each well of a 96-well
Nunc Immuno Plate MaxiSorp (Thermo Fisher Scien-
tific) and incubated at 30 °C for 2 h. Each well was
washed three times with phosphate-buffered saline (PBS;
pH 7.2) containing 0.05% Tween 20 (PBST) and then
post-coated with 300 μL 1% Block Ace (DS Pharma
Biomedical, Osaka, Japan) in 0.1 M sodium carbonate
buffer (pH 10.0) at 4 °C overnight. After the plates were
washed three times with PBST, 50 μL culture super-
natant or a standard solution optimally diluted with PBS
was added to each well and incubated at 37 °C for 2 h.
Recombinant human TARC (Shenandoah Biotechnology,
Warwick, PA, USA) was used as the standard. The plates
were then washed 3 times with PBST. Next, 100 μL of
4 μg/mL biotinylated goat anti-human TARC (R & D
systems) was added to each well and incubated at 37 °C
for 30 min. After five washes with PBST, the wells were
filled with 100 μL of 2 μg/mL horseradish peroxidase-
conjugated streptavidin (BD Biosciences, Franklin Lakes,
NJ, USA) and incubated at 37 °C for 30 min. Then, the
wells were washed five times with PBST, after which
100 μL TMB Microwell Peroxidase Substrate System
(Kirkegaard & Perry Laboratories, Gaithersburg, MD,
USA) was added to each well, and the plate was incu-
bated at 30 °C for 15 min. The reaction was stopped by
adding 100 μL 1 M phosphoric acid. The absorbance at
450 nm was measured on an iMark microplate reader
(Bio-Rad Laboratories, Hercules, CA, USA).
Statistical analysis
The results obtained in the animal study were analysed
using a Mann–Whitney U test. The results obtained in
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the cell culture study were statistically analysed using a
two-tailed Student’s t-test. P-values less than 0.05 were
considered to indicate a statistically significant difference.
Results
Effect of QSEtE treatment on Biostir-AD-induced skin
lesions in NC/Nga mice
QSEtE was obtained from the seeds of quince with a
0.3% yield on wet weight basis. To examine the effects of
QSEtE on AD-like skin lesions in vivo, NC/Nga mice
were administered different doses of QSEtE prior to
Biostir-AD application. At 1 week after the application
of QSEtE, no observable skin irritation was identified.
Repeated application of Biostir-AD macroscopically re-
sulted in AD-like lesions on the dorsal skin of mice after
3 weeks. The average clinical severity scores for each
group on day 28 were as follows: 8.2 ± 3.9 (vehicle), 2.8
± 1.7 (0.1% QSEtE), and 0.5 ± 0.8 (1.0% QSEtE) (Fig. 2).
Total clinical severity scores in QSEtE-treated groups
dose-dependently decreased compared with the scores
of vehicle-treated mice. In particular, small lesions of the
skin were observed in the 1.0% QSEtE-treated group
throughout the entire experimental period. Among the
three groups, there were no noticeable adverse effects
and no significant differences in body weight gain (data
not shown).
AD-like symptom, such as epidermal thickening and
infiltration of inflammatory cells in the dermis, were ob-
served on day 28 of the experiment (Fig. 3a). QSEtE-
treated mice showed a marked reduction in the degree
of mast cell infiltration in the skin compared to that re-
ported for the vehicle-treated mice (Fig. 3b).
a
b
Fig. 2 Effect of QSEtE pretreatment on the development of atopic dermatitis-like skin lesions in NC/Nga mice. a Clinical skin severity score. Clinical
skin severity scores of mice were measured on day 0, and every 7 days after, of the experimental period. Clinical scores are expressed as the
mean ± standard deviation (n = 6 per group). *P < 0.05 and ***P < 0.001 vs. vehicle group (Mann-Whitney’s U test). b Biostir-AD-induced skin lesions in
dorsal skin. Photographs were taken on the last day (day 28) of the experimental period
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Effect of QSEtE on serum total IgE levels of NC/Nga mice
The IgE levels in the serum of mice are shown in Fig. 4.
Serum total IgE levels of mice in the vehicle group, 0.1%
QSEtE group, and 1.0% QSEtE group were approxi-
mately 3418 ng/mL, 2108 ng/mL, and 1895 ng/mL, re-
spectively. IgE levels in 0.1% QSEtE and 1.0% QSEtE
group were significantly lower (P < 0.01) than those of
the vehicle group.
Effect of QSEtE on TARC expression in the dorsal skin of
NC/Nga mice
The TARC expression level in the dorsal skin of mice is
shown in Fig. 5. Topical application of QSEtE at the con-
centrations of 0.1 and 1.0% reduced TARC expression by
approximately 41 and 47%, respectively. These reductions
were significant in comparison with those observed for
the vehicle mice (P < 0.01 and P < 0.001, respectively).
a
b
Fig. 3 Effect of QSEtE pretreatment on skin lesions in NC/Nga mice. a Hematoxylin and eosin-stained dorsal skin lesions. b Toluidine blue-stained dor-
sal skin lesions. The histological images were taken on the last day (day 28) of the experimental period
Fig. 4 Effect of QSEtE on serum total IgE levels of NC/Nga mice. Blood samples were collected on the last day (day 28) of the experimental
period. Data are expressed as the mean ± standard error (n = 3). ***P < 0.001 vs. vehicle group (Student’s t-test)
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Effect of QSEtE treatment on TNF-α- and IFN-γ-induced
TARC expression in HaCaT cells
HaCaT cells stimulated with TNF-α and IFN-γ demon-
strated increased TARC expression levels compared with
those reported for unstimulated cells as described previ-
ously [14]. QSEtE (456, 913, 1825, 3650 or 7300 ng/mL)
suppressed TNF-α- and IFN-γ-induced TARC expression
in a dose-dependent manner (Fig. 6a). Moreover, TARC
protein secreted in the supernatant of cells was signifi-
cantly suppressed by QSEtE at 14,600 ng/mL (P < 0.01;
Fig. 6b). Under our culture conditions, no significant dif-
ference in the proliferation and viability of HaCaT cells
was observed at QSEtE concentrations ≤ 40,000 ng/mL
(data not shown).
Discussion
AD often causes a disturbance of the epidermal-barrier
function, resulting in dry skin and immune responses
against environmental allergens [15]. Various factors are
involved in the pathogenesis and development of AD. In
particular, house dust mite allergens are considered to
be the most common cause of AD [16]. In fact, extracts
from D. farinae, a common house dust mite, cause AD-
like eczematous skin lesions in NC/Nga mice [17]. In
the present study, we investigated the effect of QSEtE on
house dust mite-induced AD-like skin lesions in NC/
Nga mice.
Throughout this study, we demonstrated that QSEtE
pre-treatment dramatically reduced subsequently in-
duced dermatitis symptoms (Figs. 2 and 3a), mast cell
infiltration (Fig. 3b), and serum IgE level (Fig. 4). In
addition, we showed that TARC expression decreased in
skin lesions in mice (Fig. 5), and in in vitro cultures of
HaCaT cells (Fig. 6).
TARC, also known as CC chemokine ligand 17, is a
member of C-C chemokine family and is mainly pro-
duced by keratinocytes, dendritic cells, endothelial cells
and fibroblasts [18]. Previous studies showed that TARC
acts as a chemoattractant that guides Th2 cells that
highly express CC chemokine receptor (CCR) 4 and
CCR8 [19, 20]. Th2 cells produce chemokines, such as
RANTES, a potent chemoattractant for memory-type
cluster of differentiation 4 T cells, eosinophils and mast
cells, which results in Th2-skewed atopic inflammation
[21]. When NC/Nga mice develop AD-like lesions,
TARC is overproduced by the keratinocytes in skin le-
sions, but not in the skin without lesions [22].
In addition, TARC is produced by keratinocytes and
has been shown to accelerate inflammatory responses in
the skin of human AD patients [23]. In many cases, the
serum level of TARC is elevated in patients with AD,
and is closely associated with the disease activity of AD
[24–26]. Therefore, TARC is recognized as a therapeutic
target in the treatment of allergic disorders [27, 28]. Our
results suggest the involvement of the suppressive effect
of QSEtE on atopic symptoms and TARC production in
the skin lesions of NC/Nga mice.
As shown in Fig. 4, we also found that serum levels of
IgE were significantly suppressed in the group receiving
topical application of QSEtE as compared with that re-
ported for the vehicle-treated group. Although the
mechanism of IgE suppression by QSEtE remains
Fig. 5 Effect of QSEtE treatment on TARC expression in dorsal skin of NC/Nga mice. Dorsal skin was harvested on the last day (day 28) of the
experimental period. Data are expressed as the mean ± standard error (n = 3). **P < 0.01 and ***P < 0.001 vs. vehicle group (Student’s t-test)
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unclear, Jung et al. [29] reported that TARC-suppressive
phenolic compounds ameliorated AD symptoms
accompanied by the suppression of serum IgE. In gen-
eral, synthesis of IgE by B cells is stimulated by various
Th2 cell-derived cytokines such as IL-4, IL-5 and IL-13
[30, 31]. Elevated IgE eventually results in the develop-
ment of AD-like skin lesions by mediating mast cell de-
granulation. IgE-associated mast cell degranulation
releases inflammatory mediators such as histamine,
which increases blood vessel permeability, thus facilitat-
ing immune cell migration from the circulation to the
affected tissue, resulting in aggravation of AD symptoms
[32]. Therefore, we hypothesize that the suppression of
TARC in lesion site by QSEtE may suppress the of mast
cell recruitment and improve Th1/Th2 immune balance to
downregulate IgE production, resulting in the alleviation of
IgE- and mast cell-related atopic symptoms. In this study,
we did not determine the components responsible for
the anti-atopic effect of QSEtE. However, it should be
noted that QSEtE could easily pass through the steril-
izing filter easily, which was different from the prop-
erty of water-soluble quince seed mucilage. Additional
studies are needed to identify the primary active com-
ponents of QSEtE
Conclusions
In conclusion, we showed that the topical application of
QSEtE reduced the development of house dust mite
allergen-induced skin lesions in NC/Nga mice. In addition,
in vitro evaluations showed that QSEtE directly suppressed
TARC expression and the production of keratinocytes. Al-
though the results obtained from NC/Nga mice would be
difficult to directly extrapolate to humans owing to genetic
heterogeneity of humans, the ability of QSEtE to suppress
TARC from keratinocytes may have a role in its effectiveness
for treating AD. We believe that QSEtE could be a good
candidate to protect the skin from allergen-induced Th2-
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Fig. 6 Effect of QSEtE on TNF-α- and IFN-γ-induced TARC expression and production of HaCaT cells. a TARC mRNA expression in HaCaT cells
treated with TNF-α and IFN-γ (each 10 ng/mL) for 6 h. The expression of mRNA was measured using quantitative reverse transcription-polymerase
chain reaction. Values are expressed as the mean ± standard deviation of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001
(Student’s t-test). b TARC production in the culture supernatant of HaCaT cells treated with TNF-α and IFN-γ (each 10 ng/mL) for 24 h. Concentrations
of TARC were measured using sandwich enzyme-linked immunosorbent assay. Values are expressed as the mean ± standard deviation of three
independent experiments. **P < 0.01 (Student’s t-test)
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